Tag Archives: Evotec Strengthens Biomanufacturing Capabilities Through U.S.-Backed Program Targeting Emerging Viral Outbreaks

Evotec Subsidiary Just Evotec Biologics Advances U.S. Preparedness Efforts with New Antibody Manufacturing Initiative for Filovirus Threats

(IN BRIEF) Evotec SE’s subsidiary Just – Evotec Biologics has been selected by the Biomedical Advanced Research and Development Authority BioMaP Consortium to support a multi-year initiative aimed at improving manufacturing processes for antibody-based treatments targeting Ebola and Sudan virus. … Read the full press release